Clinical Trial Update: Gut Hormone Profiling in Obese Patients With Type 2 Diabetes (MK-0000-134)

View source ↗

Summary

This clinical trial update notes that the study evaluating gut hormone profiling in adults with morbid obesity and type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Obesity, Morbid, Diabetes Mellitus Type 2 | Status: COMPLETED